Literature DB >> 29285079

Effects of puerarin on the retina and STAT3 expression in diabetic rats.

Yonghao Cai1, Xiaobi Zhang1, Xuegu Xu1, Yinfei Yu1.   

Abstract

The effects of puerarin on electroretinogram, oxidative stress and STAT3 expression were determined, in diabetic rat retina and serum. Forty Sprague-Dawley rats were randomly divided into the normal control (NC), the diabetic model (DM), the low dose (250 mg/kg) puerarin (LP) or the high dose (500 mg/kg) puerarin group (HP). A diabetic rat model was induced by streptozotocin and animals were continuously treated for 4 weeks; fasting blood glucose was measured at 2 and 4 weeks after modeling. An electroretinogram and serum and tissue levels of glucose, insulin, superoxide dismutase (SOD), malondialdehyde (MDA) and total antioxidant capacity (T-AOC) were measured; real-time PCR and ELISA were used to determine STAT3 mRNA and protein expression, respectively, from the retina. The blood glucose and insulin levels in the puerarin groups were significantly lower and higher, respectively than that in the DM group. The amplitude of b-wave of electroretinogram in the DM and the LP groups was significantly lower than that in the NC group; in the LP and HP groups it was significantly higher than the DM group. The serum and retinal tissue activity of SOD and MDA was significantly lower and higher, respectively, in the DM group compared to the NC group; both the LP and HP groups had significantly higher SOD and lower MDA than the DM group. The levels of STAT3 mRNA and protein levels in the DM, LP and HP groups were significantly higher than the NC group; and levels of STAT3 mRNA and protein expression were significantly lower in the LP and HP groups than the DM group. In summary, puerarin can reduce the oxidative stress damage of the retina, and its mechanism is related to the inhibition of STAT3 expression.

Entities:  

Keywords:  STAT3; diabetic retinopathy; oxidative stress; puerarin; rat

Year:  2017        PMID: 29285079      PMCID: PMC5740762          DOI: 10.3892/etm.2017.5203

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  24 in total

Review 1.  The pathogenesis of early retinal changes of diabetic retinopathy.

Authors:  G B Arden; S Sivaprasad
Journal:  Doc Ophthalmol       Date:  2012-02       Impact factor: 2.379

2.  Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.

Authors:  Masuko Ushio-Fukai; Yan Tang; Tohru Fukai; Sergey I Dikalov; Yuxian Ma; Mitsuaki Fujimoto; Mark T Quinn; Patrick J Pagano; Chad Johnson; R Wayne Alexander
Journal:  Circ Res       Date:  2002-12-13       Impact factor: 17.367

3.  De novo transcriptome sequencing in Pueraria lobata to identify putative genes involved in isoflavones biosynthesis.

Authors:  Xin Wang; Shutao Li; Jia Li; Changfu Li; Yansheng Zhang
Journal:  Plant Cell Rep       Date:  2014-12-30       Impact factor: 4.570

Review 4.  Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.

Authors:  Ruth B Caldwell; Manuela Bartoli; M Ali Behzadian; Azza E B El-Remessy; Mohamed Al-Shabrawey; Daniel H Platt; Gregory I Liou; R William Caldwell
Journal:  Curr Drug Targets       Date:  2005-06       Impact factor: 3.465

Review 5.  Diabetes, oxidative stress, and antioxidants: a review.

Authors:  A C Maritim; R A Sanders; J B Watkins
Journal:  J Biochem Mol Toxicol       Date:  2003       Impact factor: 3.642

6.  The prevalence of diabetic retinopathy among adults in the United States.

Authors:  John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman
Journal:  Arch Ophthalmol       Date:  2004-04

Review 7.  STAT proteins: from normal control of cellular events to tumorigenesis.

Authors:  Valentina Calò; Manuela Migliavacca; Viviana Bazan; Marcella Macaluso; Maria Buscemi; Nicola Gebbia; Antonio Russo
Journal:  J Cell Physiol       Date:  2003-11       Impact factor: 6.384

8.  Anti-diabetic effects of puerarin, isolated from Pueraria lobata (Willd.), on streptozotocin-diabetogenic mice through promoting insulin expression and ameliorating metabolic function.

Authors:  Ka Wu; Tao Liang; Xiaoqun Duan; Lingyuan Xu; Kefeng Zhang; Rong Li
Journal:  Food Chem Toxicol       Date:  2013-08-06       Impact factor: 6.023

9.  Angiogenic and Inflammatory Vitreous Biomarkers Associated With Increasing Levels of Retinal Ischemia.

Authors:  Kyle Kovacs; Kyle V Marra; Gina Yu; Sushant Wagley; Jie Ma; Gianna C Teague; Namrata Nandakumar; Kameran Lashkari; Jorge G Arroyo
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

10.  Prevalence of diabetic retinopathy in rural China: the Handan Eye Study.

Authors:  Feng Hua Wang; Yuan Bo Liang; Feng Zhang; Jie Jin Wang; Wen Bin Wei; Qiu Shan Tao; Lan Ping Sun; David S Friedman; Ning Li Wang; Tien Yin Wong
Journal:  Ophthalmology       Date:  2009-01-24       Impact factor: 12.079

View more
  5 in total

1.  Fushiming Capsule Attenuates Diabetic Rat Retina Damage via Antioxidation and Anti-Inflammation.

Authors:  Mengshan He; Pan Long; Lunfeng Guo; Mingke Zhang; Siwang Wang; Hongling He
Journal:  Evid Based Complement Alternat Med       Date:  2019-07-18       Impact factor: 2.629

2.  Puerarin prevents cataract development and progression in diabetic rats through Nrf2/HO‑1 signaling.

Authors:  Duzhen Zhang; Man Li
Journal:  Mol Med Rep       Date:  2019-06-03       Impact factor: 2.952

Review 3.  A Narrative Review of STAT Proteins in Diabetic Retinopathy: From Mechanisms to Therapeutic Prospects.

Authors:  Libing Hong; Yongqi Lin; Min Fu; Xiongyi Yang; Tong Wu; Yuxi Zhang; Zhuohang Xie; Jieli Yu; Hejia Zhao; Guoguo Yi
Journal:  Ophthalmol Ther       Date:  2022-10-08

Review 4.  The Benefits of Flavonoids in Diabetic Retinopathy.

Authors:  Ana L Matos; Diogo F Bruno; António F Ambrósio; Paulo F Santos
Journal:  Nutrients       Date:  2020-10-16       Impact factor: 5.717

Review 5.  Molecular Mechanism of Puerarin Against Diabetes and its Complications.

Authors:  Yi-Ling Bai; Ling-Ling Han; Jun-Hui Qian; Hao-Zhong Wang
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.